Latest Breaking News On - தேசிய இருதய தகவல்கள் பதிவு - Page 3 : comparemela.com

Low 1-Year Stroke Risk After Commercial Watchman Use

May 15, 2021 The estimated 1-year rate of ischemic stroke after implantation of the Watchman left atrial appendage (LAA) closure device (Boston Scientific) was 1.53% in its first few years of commercial use in the United States, which encompassed a relatively high-risk population of patients with atrial fibrillation (AF), registry data show. That’s substantially lower than would be expected in a cohort of patients with a similar thromboembolic risk based on CHA 2DS 2-VASc score who are not taking oral anticoagulation (6.64%), Matthew Price, MD (Scripps Clinic, La Jolla, CA), reported Saturday during the virtual American College of Cardiology (ACC) 2021 Scientific Session. The low thromboembolic event rate observed in the study, which used information from the ACC’s National Cardiovascular Data Registry (NCDR) LAAO Registry, “supports the early-to-midterm clinical effectiveness of transcatheter LAAO as it is being currently utilized in the United States,” Price said.

United statesMatthew priceLos angelesChristine albertJodie hurwitzCenters for medicare medicaid servicesAmerican college of cardiologyMd smidt heart institute at cedarsDrug administrationBoston scientificNational cardiovascular data registryScripps clinicAmerican collegeCardiovascular data registrySmidt heart instituteRisk patients

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

May 15, 2021 Treating patients with atherosclerotic cardiovascular disease (ASCVD) with low-dose aspirin is just as effective as using the 325-mg dose for the prevention of major cardiovascular events, and both doses are associated with a very low rate of bleeding, according to findings from the open-label, pragmatic ADAPTABLE trial. The results, presented as a late-breaking clinical trial during the American College of Cardiology 2021 Scientific Session and published simultaneously in the New England Journal of Medicine, suggest equivalence between the two doses and should help inform clinical practice in the United States, where there is some uncertainty about the right aspirin dose for secondary prevention, say investigators.

United statesColin baigentSchuyler jonesJohn mcevoyBm bch university of oxfordMd duke university medical centerAmerican college of cardiologyMb bch national university of irelandNational cardiovascular data registryEuropean society of cardiologyAmerican college of cardiology heart associationAmerican collegeNew england journalDuke university medical centerNational universityAmerican heart association

Watchman Registry: 1-Year Stroke Estimates Reassuringly Low

Watchman Registry: 1-Year Stroke Estimates Reassuringly Low
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United statesLa jollaScripps clinicJodie hurwitzCenters for medicare medicaid servicesAmerican college of cardiologyDrug administrationBoston scientificNational cardiovascular data registryAmerican collegeMedicaid servicesMedical city hospitalஒன்றுபட்டது மாநிலங்களில்லா ஜொல்லாஸ்கிரிப்ட்கள் சிகிச்சையகம்மையங்கள் க்கு மருத்துவ மருத்துவ உதவி சேவைகள்

ISCHEMIA Trial Population Reflects Small Slice of US Practice

ISCHEMIA Trial Population Reflects Small Slice of US Practice
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNew hyde parkDavida coxSaurav chatterjeeShore university hospitalsCardiovascular associatesSociety for cardiovascular angiographyNational cardiovascular data registryCardiovascular angiographyLong island jewishNorth shore university hospitalsBrookwood baptist hospitalபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்புதியது ஹைட் பூங்கா

ISCHEMIA: PCI/CABG Has Early Hospitalization Tax but Equals Meds Later

May 06, 2021 Patients with stable ischemic heart disease treated with optimal medical therapy in the ISCHEMIA trial spent more time alive out of the hospital at 2 years when compared with those treated with an invasive strategy, but by 4 years the difference between the two approaches was a wash, according to a new analysis. When excluding hospitalizations related to the invasive protocol-assigned procedures, there was no statistically significant difference in the number of days spent alive out of hospital (DAOH) between the two treatment strategies at any time point, report investigators. “DAOH is an important patient-focused metric,” lead investigator Harvey White, DSc (Green Lane Cardiovascular Services/Auckland City Hospital, New Zealand), told TCTMD. “It’s important to measure, as patients value it. Apart from death and a debilitating stroke, patients don’t care that much about endpoints that don’t affect their quality of life. Several studies have shown that

United statesNew zealandHarvey whiteDeepak bhattSaurav chatterjeeCardiovascular services auckland city hospitalNorthwell healthSociety for cardiovascular angiographyMd north shore university hospitalLong island jewish medical centerNational cardiovascular data registryGreen lane cardiovascularAuckland city hospitalGet with theCardiovascular angiographyNorth shore university hospital